Buspirone
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Ansial, Ansiced, Anxiron, Axoren, Bespar , Buspar, Buspimen, Buspinol, Buspisal, Censpar, Lucelan, Narol, Travin, Wellbutrin XL
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Dosing and Administration
The recommended initial dose is 15 mg daily (7.5 mg b.i.d.). To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased 5 mg per day, as needed. The maximum daily dosage should not exceed 60 mg per day. In clinical trials allowing dose titration, divided doses of 20 mg to 30 mg per day were commonly employed.
The bioavailability of buspirone is increased when given with food as compared to the fasted state. Consequently, patients should take buspirone in a consistent manner with regard to the timing of dosing; either always with or always without food.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Buspirone
Return to top
Publication Resources
Most Recent Articles on Buspirone
Review Articles on Buspirone
Articles on Buspirone in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Buspirone
Return to top
Trial Resources
Ongoing Trials with Buspirone at Clinical Trials.gov
Trial Results with Buspirone
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Buspirone
Cochrane Collaboration on Buspirone
Cost Effectiveness of Buspirone
Return to top
Media Resources
Powerpoint Slides on Buspirone
Images of Buspirone
Podcasts & MP3s on Buspirone
Videos on Buspirone
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Buspirone
Discussion Groups on Buspirone
Patient Handouts on Buspirone
Blogs on Buspirone
Buspirone in the News
Buspirone in the Marketplace
Return to top
International Resources
Buspirone en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
